(Q47279363)

English

Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the Name

scientific article published on 18 December 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

1 reference

Europe PubMed Central

Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the Name (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

Hans-Georg Rammensee

2

object named as

Hans-Georg Rammensee

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

author name string

Olivera J Finn

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

publication date

18 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

Cold Spring Harbor Perspectives in Biology

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncogene-associated tumor antigens as targets for immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serological analysis of immune response to friend virus-induced leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunology of virus-induced tumours.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity to the HER-2/neu oncogenic protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity to Oncogenic Proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-rejection antigens recognized by T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor antigens are ready to fly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutated Ras peptides as vaccines in immunotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VIRUSES AND CANCER

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premalignant lesions as targets for cancer vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycoprotein tumor antigens for immunotherapy of breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The history of tumor virology

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wnt/beta-catenin signaling: components, mechanisms, and diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53 (-/-) mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wildtype p53-specific antibody and T-cell responses in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-binding properties of tumor neoepitopes in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpressed oncogenic tumor-self antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoantigens in cancer immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemia T-cell responses in CLL - We don't need no aberration

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor neoantigens: building a framework for personalized cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoepitopes of Cancers: Looking Back, Looking Ahead

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of somatic mutations in human gastrointestinal cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunoprevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Case for a Pre-Cancer Genome Atlas (PCGA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer cell associated glycans as targets for immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Basis of Oncoimmunology

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Learning from the "tsunami" of immune checkpoint inhibitors in 2015.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoantigen landscape dynamics during human melanoma-T cell interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/29254980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1101/CSHPERSPECT.A028829

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/29254980

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47279363&oldid=2150262095"